Showing 381 - 400 results of 14,224 for search '(( a ((laser decrease) OR (linear decrease)) ) OR ( a ((latent decrease) OR (largest decrease)) ))', query time: 0.44s Refine Results
  1. 381

    S1 Data - by Jordan K. Abbott (8934239)

    Published 2022
    Subjects:
  2. 382

    S13 Fig - by Jordan K. Abbott (8934239)

    Published 2022
    Subjects:
  3. 383

    S11 Fig - by Jordan K. Abbott (8934239)

    Published 2022
    Subjects:
  4. 384

    S10 Fig - by Jordan K. Abbott (8934239)

    Published 2022
    Subjects:
  5. 385
  6. 386
  7. 387
  8. 388

    Table_1_A whole cell-based Matrix-assisted laser desorption/ionization mass spectrometry lipidomic assay for the discovery of compounds that target lipid a modifications.xlsx by Wenhao Tang (839411)

    Published 2023
    “…Introduction<p>Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) is a powerful analytical technique that has been applied to a wide variety of applications ranging from proteomics to clinical diagnostics. …”
  9. 389
  10. 390

    ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alo... by Rafael de Montier P. Barroso (10366820)

    Published 2021
    “…After treatment, best-corrected visual acuity was significantly (p<0.05) improved at all follow-up visits in the group receiving intravitreal injection alone, at all but week 4 in the ETDRS group, and at all but weeks 4 and 8 for the PASCAL group. A significant decrease in central subfield macular thickness was observed in the PASCAL group at weeks 4, 8, and 48; only at week 48 in the intravitreal injection group; and never in the ETDRS group. …”
  11. 391
  12. 392
  13. 393
  14. 394
  15. 395
  16. 396
  17. 397
  18. 398
  19. 399

    Participant retention flowchart. by Carolin Oetzmann (11397968)

    Published 2025
    “…We identified a 4-class solution: (1) severe with appetite decrease, (2) severe with appetite increase, (3) moderate severity and (4) low severity. …”
  20. 400